Quetiapine Fumarate
Product Images NDC 43353-814

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Quetiapine Fumarate (NDC 43353-814). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Quetiapine Chemical Structure.jpg (3c53aaee Dc0e 42f2 A96a A5ca1f539ea4 01)

Chemical structure of quetiapine fumarate, showing the molecular arrangement of the quetiapine moiety along with the fumarate ion. The structure includes aromatic rings, nitrogen and sulfur atoms, and functional groups characteristic of quetiapine and fumarate.*

FDA Label Image

I:\dra-ma\labeling\xml Files\quetiapine Fumarate Tablets\labels\quetiapine Figure 1.jpg (3c53aaee Dc0e 42f2 A96a A5ca1f539ea4 02)

A Kaplan-Meier plot showing the proportion of patients with relapse over time (weeks). Two comparison groups are displayed: QTP+LI/VAL (dashed line) and PLA+LI/VAL (solid line). The y-axis represents the percentage of patients with relapse from 0 to 100%, and the x-axis represents time in weeks from 0 to 100. The graph shows relapse progression trends for the two groups over the study period.*

FDA Label Image

I:\dra-ma\labeling\xml Files\quetiapine Fumarate Tablets\labels\quetiapine Figure 2.jpg (3c53aaee Dc0e 42f2 A96a A5ca1f539ea4 03)

A Kaplan-Meier curve chart depicting the proportion of patients with relapse (%) over time in weeks. Two different treatment groups are represented: a solid line for PLA+LI/VAL and a dashed line for QTP+LI/VAL. The graph shows increasing relapse proportions over approximately 95 weeks, with the PLA+LI/VAL group exhibiting a higher relapse rate than the QTP+LI/VAL group throughout the timeline.*

FDA Label Image

Bottle Label 25mg (43353 813)

Label for Quetiapine Fumarate 25 mg tablets, containing 30 tablets. The label states storage instructions, manufacturer Roxane Laboratories in Columbus, OH, and repackager Aphena Pharma Solutions - Tennessee, LLC. It includes NDC number 43353-0813-30 and indicates prescription use only (RX Only).*

FDA Label Image

Bottle Label 200mg (43353 814)

Packaging label for Quetiapine Fumarate 200 mg tablets, containing 60 tablets. The label includes storage instructions, manufacturer Roxane Laboratories in Columbus, OH, and repackager Aphena Pharma Solutions - Tennessee, LLC in Cookeville, TN. The label indicates the product is for prescription use only (RX Only) and displays an NDC number and barcodes.*

FDA Label Image

Bottle Label 100mg (43353 818)

Label for Quetiapine Fumarate 100 mg tablets, pack of 45, repackaged by Aphena Pharma Solutions - Tennessee, LLC. Original manufacturer is Roxane Laboratories, Columbus, OH. The label includes storage instructions and indicates the product is RX only.*

FDA Label Image

Aphena Pharma Solutions (TN)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.